ArticleBritish journal of pharmacology2001
Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed.
Article in British journal of pharmacology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 28 citations in OpenAlex.
- Purinoceptor: a novel target for hypertension.Purinergic signalling · 2023Review
- TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy.Scientific reports · 2019Article
- Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.Purinergic signalling · 2014Article
- ATP-mediated vasodilatation occurs via activation of inwardly rectifying potassium channels in humans.The Journal of physiology · 2012Article
- Characterization of P2Y receptors mediating ATP induced relaxation in guinea pig airway smooth muscle: involvement of prostaglandins and K+ channels.Pflugers Archiv : European journal of physiology · 2011Article
- Purinergic receptors in the splanchnic circulation.Purinergic signalling · 2008Article
- A delayed ATP-elicited K+ current in freshly isolated smooth muscle cells from mouse aorta.British journal of pharmacology · 2006Article
- Biphasic effect of extracellular ATP on human and rat airways is due to multiple P2 purinoceptor activation.Respiratory research · 2005Article
- Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries.British journal of pharmacology · 2004Article
- ATP-induced vasodilation in human skeletal muscle.British journal of pharmacology · 2004Article
- Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric artery.British journal of pharmacology · 2003Article
- Purines and pyrimidines are not involved in NANC relaxant responses in the rabbit vaginal wall.British journal of pharmacology · 2002Article
- Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed.British journal of pharmacology · 2002Article
- The involvement of smooth muscle P2X receptors in the prolonged vasorelaxation response to purine nucleotides in the rat mesenteric arterial bed.British journal of pharmacology · 2002Article
- Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed.British journal of pharmacology · 2001Article
- Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat.British journal of pharmacology · 2001Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1. This study investigated the mechanism of prolonged relaxation to ATP in the rat isolated perfused mesenteric arterial bed. 2. In methoxamine pre-constricted preparations, ATP elicited dose-dependent, endothelium-dependent, rapid relaxation at 5 pmol - 0.05 micromol (R(max) 76+/-5.6%, pD(2) 9.2+/-0.2), and contraction, followed by prolonged endothelium-independent vasorelaxation at 0.05, 0.5 and 5 micromol (56+/-3.0, 87+/-2.9 and 85+/-4.6%). Suramin (100 microM), attenuated rapid (pD(2) 7.8+/-0.1) and prolonged relaxation to ATP. The selective P2 receptor antagonist PPADS (10 microM) reduced prolonged, but not rapid relaxation. Neither phase of relaxation was affected by 8-sulphophenyltheophylline (1 microM) or indomethacin (10 microM). 3. alpha,beta-methylene ATP (alpha,beta-meATP; 10 microM) attenuated prolonged relaxation to ATP (relaxations at 0.05 and 0.5 micromol were 25+/-8.3 and 48+/-9.0%, respectively). alpha,beta-meATP blocked contractions and revealed rapid relaxation to ATP at 0.05 - 5 micromol. 4. Capsaicin pre-treatment did not affect either phase of vasorelaxation to ATP. alpha,beta-meATP (10 microM) had no effect on vasorelaxation mediated by electrical stimulation of capsaicin-sensitive sensory nerves. 5. High K(+) (25 mM) attenuated prolonged relaxation to ATP (21+/-2.6 and 64+/-5.8%, at 0.05 and 0.5 micromol, respectively), but had no effect on rapid relaxation. Ouabain (1 mM), an inhibitor of Na(+)/K(+)-ATPase, and glibenclamide (10 microM), an inhibitor of K(ATP) channels, also attenuated prolonged relaxation to ATP. Charybdotoxin (100 nM), a selective inhibitor of K(Ca) channels, and tetraethylammonium (10 mM) had no effect on rapid or prolonged relaxations. 6. These results show that the prolonged phase of vasorelaxation to ATP in the rat isolated mesenteric arterial bed, which may be mediated by P2Y receptors, is endothelium-independent, involves activation of Na(+)/K(+)-ATPase and K(ATP) channels, and is inhibited by alpha,beta-meATP. Neither prolonged nor rapid vasorelaxation to ATP involves capsaicin-sensitive sensory nerves, adenosine P1 receptors, prostanoids or K(Ca) channels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.